Literature DB >> 21889460

Microsecond unfolding kinetics of sheep prion protein reveals an intermediate that correlates with susceptibility to classical scrapie.

Kai-Chun Chen1, Ming Xu, William J Wedemeyer, Heinrich Roder.   

Abstract

The microsecond folding and unfolding kinetics of ovine prion proteins (ovPrP) were measured under various solution conditions. A fragment comprising residues 94-233 of the full-length ovPrP was studied for four variants with differing susceptibilities to classical scrapie in sheep. The observed biexponential unfolding kinetics of ovPrP provides evidence for an intermediate species. However, in contrast to previous results for human PrP, there is no evidence for an intermediate under refolding conditions. Global analysis of the kinetic data, based on a sequential three-state mechanism, quantitatively accounts for all folding and unfolding data as a function of denaturant concentration. The simulations predict that an intermediate accumulates under both folding and unfolding conditions, but is observable only in unfolding experiments because the intermediate is optically indistinguishable from the native state. The relative population of intermediates in two ovPrP variants, both transiently and under destabilizing equilibrium conditions, correlates with their propensities for classical scrapie. The variant susceptible to classical scrapie has a larger population of the intermediate state than the resistant variant. Thus, the susceptible variant should be favored to undergo the PrP(C) to PrP(Sc) conversion and oligomerization.
Copyright © 2011 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889460      PMCID: PMC3164147          DOI: 10.1016/j.bpj.2011.07.024

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  58 in total

1.  Physical studies of conformational plasticity in a recombinant prion protein.

Authors:  H Zhang; J Stockel; I Mehlhorn; D Groth; M A Baldwin; S B Prusiner; T L James; F E Cohen
Journal:  Biochemistry       Date:  1997-03-25       Impact factor: 3.162

2.  Familial mutations and the thermodynamic stability of the recombinant human prion protein.

Authors:  W Swietnicki; R B Petersen; P Gambetti; W K Surewicz
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

Review 3.  The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways.

Authors:  J W Kelly
Journal:  Curr Opin Struct Biol       Date:  1998-02       Impact factor: 6.809

4.  The cellular prion protein binds copper in vivo.

Authors:  D R Brown; K Qin; J W Herms; A Madlung; J Manson; R Strome; P E Fraser; T Kruck; A von Bohlen; W Schulz-Schaeffer; A Giese; D Westaway; H Kretzschmar
Journal:  Nature       Date:  1997 Dec 18-25       Impact factor: 49.962

5.  A continuous-flow capillary mixing method to monitor reactions on the microsecond time scale.

Authors:  M C Shastry; S D Luck; H Roder
Journal:  Biophys J       Date:  1998-05       Impact factor: 4.033

6.  Kinetic evidence for folding and unfolding intermediates in staphylococcal nuclease.

Authors:  W F Walkenhorst; S M Green; H Roder
Journal:  Biochemistry       Date:  1997-05-13       Impact factor: 3.162

7.  NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231).

Authors:  R Riek; S Hornemann; G Wider; R Glockshuber; K Wüthrich
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

8.  Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.

Authors:  S Liemann; R Glockshuber
Journal:  Biochemistry       Date:  1999-03-16       Impact factor: 3.162

9.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.

Authors:  D G Donne; J H Viles; D Groth; I Mehlhorn; T L James; F E Cohen; S B Prusiner; P E Wright; H J Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

Review 10.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  7 in total

1.  Comparing the folding and misfolding energy landscapes of phosphoglycerate kinase.

Authors:  Gergely Agócs; Bence T Szabó; Gottfried Köhler; Szabolcs Osváth
Journal:  Biophys J       Date:  2012-06-19       Impact factor: 4.033

2.  Nanopore analysis reveals differences in structural stability of ovine PrP(C) proteins corresponding to scrapie susceptible (VRQ) and resistance (ARR) genotypes.

Authors:  Claudia Avis Madampage; Kristen Marciniuk; Pekka Määttänen; Neil R Cashman; Andrew Potter; Jeremy S Lee; Scott Napper
Journal:  Prion       Date:  2014-01-08       Impact factor: 3.931

3.  Microsecond folding dynamics of apomyoglobin at acidic pH.

Authors:  Ming Xu; Olga Beresneva; Ryan Rosario; Heinrich Roder
Journal:  J Phys Chem B       Date:  2012-04-17       Impact factor: 2.991

4.  Thermodynamic characterization of the unfolding of the prion protein.

Authors:  Roumita Moulick; Jayant B Udgaonkar
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

5.  Advances in Mixer Design and Detection Methods for Kinetics Studies of Macromolecular Folding and Binding on the Microsecond Time Scale.

Authors:  Takuya Mizukami; Heinrich Roder
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

6.  A Native-like Intermediate Serves as a Branching Point between the Folding and Aggregation Pathways of the Mouse Prion Protein.

Authors:  Ryo P Honda; Ming Xu; Kei-Ichi Yamaguchi; Heinrich Roder; Kazuo Kuwata
Journal:  Structure       Date:  2015-08-06       Impact factor: 5.006

7.  Partially Unfolded Forms of the Prion Protein Populated under Misfolding-promoting Conditions: CHARACTERIZATION BY HYDROGEN EXCHANGE MASS SPECTROMETRY AND NMR.

Authors:  Roumita Moulick; Ranabir Das; Jayant B Udgaonkar
Journal:  J Biol Chem       Date:  2015-08-25       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.